<!DOCTYPE html>
<html lang="en">

<head>

    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="">
    <meta name="author" content="">

    <title>ARTIST</title>

    <!-- Bootstrap Core CSS -->
    <link rel="stylesheet" href="css/bootstrap.min.css" type="text/css">

    <!-- Custom Fonts -->
    <link href='http://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,300,600,700,800' rel='stylesheet' type='text/css'>
    <link href='http://fonts.googleapis.com/css?family=Merriweather:400,300,300italic,400italic,700,700italic,900,900italic' rel='stylesheet' type='text/css'>
    <link rel="stylesheet" href="font-awesome/css/font-awesome.min.css" type="text/css">

    <!-- Plugin CSS -->
    <link rel="stylesheet" href="css/animate.min.css" type="text/css">

    <!-- Custom CSS -->
    <link rel="stylesheet" href="css/creative.css" type="text/css">

    
    <link rel="stylesheet" href="css/sweet-alert.css" />

    <link rel="stylesheet" href="css/jcarousel.skeleton.css">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.4.2/respond.min.js"></script>
    <![endif]-->

</head>

<!-- Landing page -->
<body id="page-top" onload="storeVisited()">

    <nav id="mainNav" class="navbar navbar-default navbar-fixed-top">
        <div class="container-fluid">
            <!-- Brand and toggle get grouped for better mobile display -->
            <div class="navbar-header">
                <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1">
                    <span class="sr-only">Toggle navigation</span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
                <a class="navbar-brand page-scroll bolden" href="#page-top">ARTIST</a>
            </div>

            <!-- Collect the nav links, forms, and other content for toggling -->
            <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">
                <ul class="nav navbar-nav navbar-right">
                    <li>
                        <a class="page-scroll" href="#coreE">Techniques</a>
                    </li>
                    <li>
                        <a class="page-scroll" href="#risks">Risk</a>
                    </li>
                    <li>
                        <a class="page-scroll" href="#social-legal">Social-legal</a>
                    </li>
                </ul>
            </div>
            <!-- /.navbar-collapse -->
        </div>
        <!-- /.container-fluid -->
    </nav>

    <header>
        <div class="header-content">
            <div class="header-content-inner">
                <h1>ARTIST</h1>
                <hr>
                <a href="#coreE" class="btn btn-primary btn-xl page-scroll">Techniques</a>
                <a href="#risks" class="btn btn-primary btn-xl page-scroll">Risks</a>
                <a href="#social-legal" class="btn btn-primary btn-xl page-scroll">Social-legal</a>
            </div>
        </div>
    </header>

    <!-- Intro wording -->
    <div id="begin" class="text-center row">
        <section class="col-md-10 col-md-offset-1" style="font-family:sarif;">
            <h1>
                 Our goal is to help you better understand Assisted Reproduction before you consent
            </h1>
            <hr>
            <div class="col-md-10 col-md-offset-1" style="font-size:large;">
                <h3 style="text-align: justify;">
                    Consent forms are aimed to verify your understanding of your medical treatment
                    Currently, the Assisted Reproduction consent form exceeds 20 pages in length! Although not all procedures may apply to you, our goal is to give you a better way to understand the following procedures:
                </h3><br>
            </div>
        </section>
    </div>

    <div id="coreE">
        <!-- core elements Section -->
        <section id="core_elements">
            <div class="container">
                <div class="row">
                    <div class="col-lg-12 text-center">
                        <h2 class="section-heading">Core Elements</h2>
                        <h3 class="section-subheading text-muted">And Their Risks.</h3>
                    </div>
                </div>
                <div class="row room">
                    <div class="col-md-4 col-sm-6 portfolio-item">
                        <a id="medicationImage" href="#medication_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                        <img  src="images/medications.jpg" class="img-responsive" alt="">
                        <div class="portfolio-box-caption">
                            <div class="portfolio-box-caption-content">
                                <div class="project-category text-faded">
                                    Medications
                                </div>
                            </div>
                        </div>
                    </a>
                    </div>
                    <div class="col-md-4 col-sm-6 portfolio-item">
                        <a id="oocyteImage" href="#oocyte_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                        <img src="images/transvag.jpg" class="img-responsive" alt="">
                        <div class="portfolio-box-caption">
                            <div class="portfolio-box-caption-content">
                                <div class="project-category text-faded">
                                    Transvaginal Oocyte Retrieval
                                </div>
                            </div>
                        </div>
                    </a>
                    </div>
                    <div class="col-md-4 col-sm-6 portfolio-item">
                        <a id="ebryoImage" href="#embryo_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                        <img src="images/embryo_transfer.jpg" class="img-responsive" alt="">
                        <div class="portfolio-box-caption">
                            <div class="portfolio-box-caption-content">
                                <div class="project-category text-faded">
                                    Embryo Transfer
                                </div>
                            </div>
                        </div>
                    </a>
                    </div>
                </div>
                <div class="row">
                    <div class="col-md-2 hidden-sm portfolio-item"></div>
                    <div class="col-md-4 col-sm-6 portfolio-item">
                        <a id="cultureImage" href="#ivf_culture_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                        <img src="images/culture.jpg" class="img-responsive" alt="">
                        <div class="portfolio-box-caption">
                            <div class="portfolio-box-caption-content">
                                <div class="project-category text-faded">
                                    IVF and Embryo Culture
                                </div>
                            </div>
                        </div>
                    </a>
                    </div>
                    <div class="col-md-4 2 hidden-sm portfolio-item">
                        <a id="hormonalImage" href="#hormonal_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                        <img src="images/hormone.jpg" class="img-responsive" alt="">
                        <div class="portfolio-box-caption">
                            <div class="portfolio-box-caption-content">
                                <div class="project-category text-faded">
                                    Hormonal Support of Uterine Lining
                                </div>
                            </div>
                        </div>
                    </a>
                    </div>
                </div>
            </div>
        </section>

        <!-- additional elements section -->
        <section id="additional_elements" class="bg-light-gray">
            <div class="container">
                <div class="row">
                    <div class="col-lg-12 text-center">
                        <h2 class="section-heading">Additional Elements</h2>
                        <h3 class="section-subheading text-muted">And Their Risks.</h3>
                    </div>
                </div>
                <div class="row">
                    <div class="col-md-3 col-sm-6 portfolio-item">
                        <a id="icsiImage" href="#sperm_injection_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                            <img src="images/injection.jpg" class="img-responsive" alt="">
                            <div class="portfolio-box-caption">
                            <div class="portfolio-box-caption-content">
                                <div class="project-category text-faded">
                                    Intracytoplasmic Sperm Injection (ICSI)
                                </div>
                            </div>
                            </div>
                        </a>
                    </div>
                <div class="col-md-3 col-sm-6 portfolio-item">
                    <a id="hatchImage" href="#hatchling_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                        <img src="images/hatching.jpg" class="img-responsive" alt="">
                        <div class="portfolio-box-caption">
                        <div class="portfolio-box-caption-content">
                            <div class="project-category text-faded">
                                Assisted Hatchling
                            </div>
                        </div>
                        </div>
                    </a>
                </div>
                    <div class="col-md-3 col-sm-6 portfolio-item">
                        <a id="dispoImage" href="#embryo_disp_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                            <img src="images/embryo_disposition.jpg" class="img-responsive" alt="">
                            <div class="portfolio-box-caption">
                                <div class="portfolio-box-caption-content">
                                    <div class="project-category text-faded">
                                        Embryo Disposition
                                    </div>
                                </div>
                            </div>
                        </a>
                    </div>
                    <div class="col-md-3 col-sm-6 portfolio-item">
                        <a id="researchImage" href="#research_modal" class="portfolio-box portfolio-link content" data-toggle="modal">
                            <img src="images/fate.jpg" class="img-responsive" alt="">
                            <div class="portfolio-box-caption">
                                <div class="portfolio-box-caption-content">
                                    <div class="project-category text-faded">
                                        Donated or Research Embryo Fate
                                    </div>
                                </div>
                            </div>
                        </a>
                    </div>
                </div>
                </div>
        </section>
    </div>

    <!-- risks social legal section -->
    <div id="risks">
        <section class="container">
            <div class="row">
                <div class="col-lg-12 text-center">
                    <h2 class="section-heading">Risks</h2>
                    <br><br>
                </div>
            </div>
            <div class="row">
                <div class="col-md-4 col-sm-6 portfolio-item">
                    <a id="femaleIcon" href="#risks_to_women_modal" class="portfolio-link content" data-toggle="modal">
                        <div class="img-responsive text-center" style="width:360px;height:100px;">
                            <i  class="fa fa-female fa-4x"></i>
                        </div>
                    </a>
                    <div class="portfolio-caption text-center">
                        <h4>Risks to the Woman</h4>
                    </div>
                </div>
                <div class="col-md-4 col-sm-6 portfolio-item">
                    <a id="childIcon" href="#risks_to_offrping" class="portfolio-link content" data-toggle="modal">
                        <div class="img-responsive text-center" style="width:360px;height:100px;">
                            <i  class="fa fa-child fa-4x"></i>
                        </div>
                    </a>
                    <div class="portfolio-caption text-center">
                        <h4>Risks to Offspring</h4>
                    </div>
                </div>
                <div class="col-md-4 col-sm-6 portfolio-item">
                    <a id="stethoscopeIcon" href="#alt_modal" class="portfolio-link content" data-toggle="modal">
                        <div class="img-responsive text-center" style="width:360px;height:100px;">
                            <i  class="fa fa-stethoscope fa-4x"></i>
                        </div>
                    </a>
                    <div class="portfolio-caption text-center">
                        <h4>Alternatives</h4>
                    </div>
                </div>
            </div>
        </section>
    </div>
    <div id="social-legal">
        <section class="container">
            <div class="row">
                <div class="col-lg-12 text-center">
                    <h2 class="section-heading">Social Legal</h2>
                    <br><br>
                </div>
            </div>
        <div class="row">
            <!-- used for spacing -->
            <div class="col-md-4 col-sm-6 portfolio-item">
                <a href="#" class="portfolio-link content" data-toggle="modal"></a>
            </div> <!-- end spacing -->

            <div class="col-md-4 col-sm-6portfolio-item">
                <a id="legalIcon" href="#social_modal" class="portfolio-link content" data-toggle="modal">
                    <div class="img-responsive text-center" style="width:360px;height:100px;">
                        <i  class="fa fa-legal fa-4x"></i>
                    </div>
                </a>
                <div class="portfolio-caption text-center">
                    <h4>Social Legal</h4>
                </div>
            </div>

            <!-- used for spacing -->
            <div class="col-md-4 col-sm-6 portfolio-item">
                <a href="#" class="portfolio-link" data-toggle="modal"></a>
            </div><!-- end spacing -->
        </div>
        </section>
    </div>

    <!--Footer-->
    <footer>
        <div class="container">
            <div class="row">
                <div class="col-md-4">
                    <span class="copyright">Copyright &copy; 2015 Wright State University</span>
                </div>
                <div class="col-md-4">
                    
                </div>
                <div class="col-md-4">
                    <ul class="list-inline quicklinks">
                        <li><a href="#">Privacy Policy</a>
                        </li>
                        <li><a href="#">Terms of Use</a>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
    </footer>


    <!--END OF PAGE #######################################-->


    <!-- medication_modal -->
    <div class="portfolio-modal modal fade" id="medication_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div id="about" class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl"></div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                <div class="col-lg-12 text-center">
                <h2 class="section-heading">Medications</h2>
                
                    <p>The success of ivf largely depends on growing multiple eggs at once</p>
                    <p>Injections of the natural hormones fsh and/or lh (gonadotropins) are used for this purpose</p> 
                    <p>Additional medications are used to prevent premature ovulation</p> 
                    <p>An overly vigorous response can occur, or conversely an inadequate response</p> 
                
                </div>
                </div>
                <div class="row">
                    <div class="col-lg-12 ">
                        
                        <div class="jcarousel-wrapper">
                            <div class="jcarousel">
                            <ul>
                                <li>
                                    <div>
                                    <h2>Gonadotropins</h2>
                                    <h1>“fertility drugs”</h1>
                                    <sub>(Follistim®, Gonal-F®, Bravelle®, Menopur®)</sub>
                                    <p ><br>These medications are used to stimulate the ovaries to induce growing eggs (oocytes) over 8+ days. They contain the hormones FSH and LH.</p>
                                    </div>
                                    <h3>Risks:</h3>
                                    
                                    <ul>
                                        <li>Bloating</li>
                                        <li>Headache/Fatigue</li>
                                        <li>Nausea</li>
                                        <li>Weight gain</li>
                                        <li>Mood swings</li>
                                        <li>Blood clots</li>
                                        <li>Bruising, redness, swelling, or discomfort at injection site</li>
                                        <li>Up to 2% develop OHSS *link to OHSS in risks to woman section</li>
                                        <li>Ovarian cancer (risks are associated with infertility itself and NOT necessarily with fertility medications)</li>
                                    </ul>
                                  
                                    
                                </li>
                                <li>
                                    <div>
                                    <h2>GnRH-agonists</h2>
                                    <h1>(Leuprolide acetate)</h1>
                                    <sub>(Lupron®)</sub>
                                    <p ><br>The primary role of this medication is to prevent a premature LH surge, which could result in the release of eggs before they are ready to be retrieved. Additionally, it can be used to start the growth of the follicles or initiate the final stages of egg maturation. There are two forms of the medication: A short acting medication requiring daily injections and a long-acting preparation lasting for 1-3 months.  GnRH-agonists have not been associated with any fetal malformations, however, you should discontinue use as soon as pregnancy is confirmed.</p>.
                                    </div>
                                    <h3>Risks:</h3>
                                    <ul >
                                        <li>Hot flashes</li>
                                        <li>Vaginal dryness</li>
                                        <li>Bone loss</li>
                                        <li>Nausea</li>
                                        <li>Vomiting</li>
                                        <li>Skin reactions at injection site</li>
                                        <li>Fluid retention</li>
                                        <li>Muscle aches</li>
                                        <li>Headaches</li>
                                        <li>Depression</li>
                                    </ul>
                                </li>
                                <li>
                                    <div>
                                    <h2>GnRH-antagonists</h2>
                                    <h1>(Ganirelix Acetate or Cetrorelix Acetate)</h1>
                                    <sub>(Antagon®, Cetrotide®)</sub>
                                    <p ><br>The purpose of these medications is to prevent premature ovulation. GnRH-antagonists are used for short periods of time in the late stages of ovarian stimulation and are administered by injection.</p>
                                    </div>
                                    <h3>Risks:</h3>
                                    <ul >
                                        <li>Abdominal pain</li>
                                        <li>Headaches</li>
                                        <li>Skin reaction at injection site</li>
                                        <li>Nausea</li>
                                    </ul>
                                </li>
                                <li>
                                    <div>
                                    <h2>Human Chorionic Gonadotropin</h2>
                                    <h1>(hCG)</h1>
                                    <sub>(Novarel®, Pregnyl®, Ovidrel®)</sub>
                                    <p ><br>hCG is a hormone used in IVF cycles to induce the eggs to become mature and fertilizable.  The timing of this medication is critical to retrieve mature eggs. hCG is administered by injection.</p>
                                    </div>
                                    <h3>Risks:</h3>
                                    <ul >
                                        <li>Breast tenderness</li>
                                        <li>Bloating</li>
                                        <li>Pelvic discomfort</li>
                                    </ul>
                                </li>
                                <li>
                                    <div>
                                    <h2>Progesterone</h2>
                                    <sub>(Endometrin®, Crinone®, Prochieve®, Prometrium®)</sub>
                                    <h1>and Estradiol (Estrace)</h1>
                                    <p ><br>Progesterone and estradiol are hormones used to ensure adequate hormonal support of the uterine lining. Progesterone can be administered by an injection or vaginally after egg retrieval. Estradiol can be administered orally, trans-dermally, intramuscularly, or vaginally.</p>
                                    </div>
                                    <h3>Risks:</h3>
                                    <h5 >Progesterone:</h5>
                                    <ul >
                                        <li>Has <strong>NOT</strong> been associated with fetal abnormalities</li>
                                        <li>Depression</li>
                                        <li>Sleepiness</li>
                                        <li>Allergic reaction</li>
                                        <li>If given by intramuscular injection, possible infection or pain at site of application</li>
                                    </ul>
                                    <h5 >Estradiol:</h5>
                                    <ul >
                                        <li>Nausea</li>
                                        <li>Irritation at injection site</li>    
                                        <li>If given by trans-dermal route, risk of blood clots or stroke</li>
                                    </ul>
                                </li>
                                <li>
                                    <div>
                                    <h2>Oral contraceptive pills (OCP)</h2>
                                    <h2>and Estradiol (Estrace)</h2>
                                    <p ><br>In order to suppress hormone production or to schedule a cycle, OCPs are taken for 2-4 weeks or Estrace 1-4 weeks before gonadotropin injections. Since Estrace is sometimes administered after ovulation and prior to menses, it is possible that it can be taken early in pregnancy. The safest course of action while using Estrace is to use a barrier method of contraception (condoms) during the month you start Estrace.</p>
                                    </div>
                                    <h3>Risks:</h3>
                                    <ul >
                                        <li>Unscheduled bleeding</li>
                                        <li>Headache</li>
                                        <li>Breast tenderness</li>
                                        <li>Nausea</li>
                                        <li>Swelling</li>
                                        <li>Risk of blood clot and stroke</li>
                                        <li>Estrace has <strong>not</strong> been associated with any fetal malformations, but you may be told to discontinue use as soon as pregnancy is confirmed</li>
                                    </ul>
                                </li>
                                <li>
                                <div>
                                    <h2>Other medications</h2>
                                        <h3>Antibiotics</h3>
                                            <p>Given for a short period of time to reduce risk of infection associated with egg retrieval or embryo transfer</p>
                                </div>
                                            <h3>Risks:</h3>
                                            <ul >
                                              <li>yeast infection</li>
                                              <li>nausea</li>
                                              <li>vomiting</li>
                                              <li>diarrhea</li>
                                              <li>rashes</li>
                                              <li>sensitivity to the sun</li>
                                              <li>allergic reactions</li>
                                            </ul>
                                    <div>
                                    <h3>Anti-anxiety or muscle relaxants</h3>
                                      <p>May be recommended prior to embryo transfer</p>
                                    </div>
                                        <h3>Risks:</h3>
                                         <ul >
                                             <li>most common side effect is drowsiness</li>
                                         </ul>
                                    <div>
                                    
                                      <p >Steroids</p>
                                      <p >Heparin</p>
                                      <p >Low molecular weight heparin</p>
                                      <p >Aspirin</p>
                                    
                                    </div>
                                  
                                </li>
                            </ul>
                            <!-- Prev/next controls -->
                            <a href="#" class="jcarousel-prev">&lsaquo; Prev</a>
                            <a href="#" class="jcarousel-next">Next &rsaquo;</a>

                            <!-- Pagination -->
                            <p class="jcarousel-pagination">
                            <!-- Pagination items will be generated in here -->
                            </p>
                            </div>

                    </div>
                    <button type="button" onclick="success()"class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                </div>
            </div>
        </div>
   </div>
   </div>

    <!-- oocyte_modal-->
    <div class="portfolio-modal modal fade" id="oocyte_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <h2>Transvaginal Oocyte Retrieval</h2>
                            <ul>
                                <li>Eggs are removed from the ovary with a needle under ultrasound guidance</li>
                                <li>Anesthesia is provided to make this comfortable</li>
                                <li>Injury and infection are rare</li>
                            </ul>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- embryo_modal -->
    <div class="portfolio-modal modal fade" id="embryo_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Embryo transfer</h2>
                            <ul>
                                <li>After a few days of development, the best appearing embryos are selected for transfer</li>
                                <li>The number chosen influences the pregnancy rate and the multiple pregnancy rate</li>
                                <li>A woman’s age and the appearance of the developing embryo have the greatest influences on pregnancy outcome</li>
                                <li>Emryos are placed in the uterine cavity with a thin tube</li>
                                <li>Excess embryos of sufficient quality that are not transferred can be frozen </li>
                                <li>Recommendation charts (add in)</li>
                            </ul>
                            
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- ivf_culture_modal 4 -->
    <div class="portfolio-modal modal fade" id="ivf_culture_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>IVF and Embryo Culture</h2>
                            <ul>
                                <li>Sperm and eggs are placed together in specialized conditions (culture media, controlled temperature, humidity, and light) in hopes of fertilization</li>
                                <li>Culture medium is designed to permit normal fertilization and early embryo development, but the content of the media is not standardized</li>
                                <li>Embryo development in the lab helps distinguish embryos with more potential from those with less or none</li>
                            </ul>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- hormonal_modal -->
    <div class="portfolio-modal modal fade" id="hormonal_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Hormonal Support of Uterine Lining</h2>
                            <ul>
                                <li>Successful attachment of embryo(s) to the uterine lining depends on adequate hormonal support</li>
                                <ul>
                                    <li>Progesterone</li>
                                        <ul>
                                            <li>Administered by intramuscular or vaginal route for 2 to 10 weeks</li>
                                            <li>Routinely prescribed</li>
                                        </ul>
                                    <li>Estradiol</li>
                                    <ul>
                                        <li>Administered by oral, vaginal, intramuscular or transdermal route for 2 to 10 weeks</li>
                                        <li>Sometimes prescribed</li>
                                    </ul>
                                </ul>
                            </ul>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- sperm_injection_modal -->
    <div class="portfolio-modal modal fade" id="sperm_injection_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Intracytoplasmic Sperm Injection (ICSI)</h2>
                            <ol>
                                <li>Purpose:</li>
                                <ol id="drop">
                                    <li><span>ICSI is used to increase the chance of fertilization when fertilization rates are anticipated to be lower than normal due to <em><u><i>male factor infertility</em></i></u></span>
                                        <ol>
                                            <li>Abnormal semen characteristics</li>
                                            <li>Sperm problems (low count, poor motility, abnormal shape)</li>
                                            <li>Congenital bilateral absence of the vas deferens (CBAVD)</li>
                                        
                                                <ol>
                                                    <li>Infertility caused by failure of the tubes connecting the testes to the penis to develop correctly</li>
                                                    <li>Associated with Cystic Fibrosis</li>
                                                    <li>Can be bypassed by aspirating sperm directly from the testicles or epididymis, and using them in IVF with ICSI to achieve fertilization</li>
                                                </ol>
                                            <li>Non-obstructive azoospermia</li>
                                                <ol>
                                                    <li>Lack of sperm in ejaculate caused by failure of testes to produce sperm</li>
                                                </ol>
                                        </span></ol>
                                        </li>
                                </ol>
                                <li>Procedure:</li>
                                    <ol>
                                        <li>ICSI involves the direct injection of a single sperm into the interior of an egg using an extremely thin glass needle</li>
                                    </ol>
                                <li>Birth Defect Risks:</li>
                                    <ol>
                                        <li>The absolute risk is very low. This risk is mainly related to infertility factors rather than IVF procedure. </li>
                                    </ol>
                                <li>Genetic Related Risks:</li>
                                    <ol>
                                        <li>An increased risk of genetic defects in offspring is reported</li>
                                        <li>ICSI will not improve oocyte defects</li>
                                        <li>Sex Chromosome Abnormalities</li>
                                            <ol>
                                                <li>Prevalence is slightly higher in children conceived via ICSI than is observed in the general IVF population (0.8% to 1.0% in ICSI offspring versus 0.2% in the general IVF population)</li>
                                                <li>May reflect a direct paternal effect</li>
                                            </ol>
                                        <li>CBAVD and CF</li>
                                            <ul>
                                                <li>Men with CBAVD are affected with a mild form of cystic fibrosis (CF), and this gene will be passed on to their offspring</li>
                                            </ul>
                                    </ol>
                            </ol>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- hatchling_modal -->
    <div class="portfolio-modal modal fade" id="hatchling_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Assisted Hatching</h2>
                            <ol>
                                <li>Assisted hatching involves making a hole in the outer shell (zona pellucid) that surounds the embryo</li>
                                <li>Hatching may make it easier for embryoes to espace from the shell which surrounds them</li>
                            </ol>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- embryo_disp_modal -->
    <div class="portfolio-modal modal fade" id="embryo_disp_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Embryo Disposition</h2>
                            <ol>
                                <li>Freezing of viable embryos not transferred after egg retrieval provides additional changes for pregnancy </li>
                                <li>Frozen embryos do not always survive the process of freezing and thawing</li>
                                <li>Freezing eggs before fertilization is currently less successful than freezing of fertilized eggs (embryos)</li>
                                <li>Ethical and legal dilemmas can arise when couples separate or divorce; disposition agrements are essential</li>
                                <li>It is the responsibility of each couple with frozen embryoes to remain in contact with ari on quarterly basis</li>
                                <li>Cryopreservation</li>
                                    <ol>
                                        <li>Purpose:</li>
                                            <ul>
                                                <li>Remaining oocytes or embryos following IVF may be frozen (or “cryopreserved”) for future use</li>
                                            </ul>
                                        <li>Summary of Indications:</li>
                                            <ul>
                                                <li>To reduce the risks of multiple gestation</li>
                                                <li>To preserve fertility potential in the face of certain necessary medical procedures</li>
                                                <li>To increase the chance of having one or more pregnancies from a single cycle of ovarian stimulation</li>
                                                <li>To minimize the medical risk and cost to the patient by decreasing the number of stimulated cycles and egg retrievals</li>
                                                <li>To temporarily delay pregnancy and the risk of OHSS <a href="#">(link to OHSS)</a> </li>
                                            </ul>
                                        <li>Risks:</li>
                                            <ul>
                                                <li>Overall pregnancy rates at the national level with frozen embryos are lower than with fresh embryos.</li>
                                                <li>Data do not indicate any likelihood that children born of embryos that have been cryopreserved and thawed will experience greater risk of abnormalities than those born of fresh embryos.</li>
                                            </ul>
                                    </ol>
                                <li>Legal Considerations</li>
                                    <ol>
                                        <li>Because of the possibility of you and/or your partner’s separation, death or incapacitation, it is important to decide on the disposition of any embryo(s), fresh or cryopreserved that remain in the laboratory. Since this is a rapidly evolving field, both medically and legally, ARI cannot guarantee what the available or acceptable avenues for disposition will be at any future date</li>
                                        <li>Alternatives:</li>
                                            <ul>
                                                <li>Discarding the cryopreserved embryo(s)</li>
                                                <li>Donating the cryopreserved embryo(s) for approved research studies</li>
                                                <li>Donating the cryopreserved embryos to another couple in order to attempt pregnancy (You may be asked to undergo additional infectious disease testing and screening recommended by the FDA if you select this option.)</li>
                                            </ul>
                                        <li>Embryos are understood to be your property, with rights of surviorship. No use can be made of these embryos without the consent of both partners (if applicable)</li>
                                            <ul>
                                                <li>In the event of divorce or dissolution of the marriage or partnership, the ownership and/or other rights to the embryo(s) will be as directed by the court decree and/or settlement agreement</li>
                                                <li>In the event of the death or incapacitation of one partner, the embryo(s) will become the sole and exclusive property of the surviving partner</li>
                                                <li>In the event of death or incapacitation of both partners or of a last surviving partner, the embryo(s) shall become the sole and exclusive property of ARI. In this event, I/we elect to: (please select and initial your choice)</li>
                                                    <ul>
                                                        <li>Insert chart</li>
                                                    </ul>
                                            </ul>
                                    </ol>
                            </ol>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- research_modal -->
    <div class="portfolio-modal modal fade" id="research_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>research_modal</h2>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- risks_to_woman -->
    <div class="portfolio-modal modal fade" id="risks_to_women_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Risks to the Woman</h2>
                            <ol>
                            <li> Ovarian Hyperstimulation Syndrome
                                <ol>
                                <li>OHSS is the most serious side effect of ovarian stimulation</li>
                                <li> Symptoms:
                                    <ol>
                                    <li> Increased ovarian size</li>
                                    <li> Nausea and vomiting</li>
                                    <li> Accumulation of fluid in the abdomen</li>
                                    <li> Breathing difficulties</li>
                                    <li> Increased concentration of red blood cells</li>
                                    <li> Kidney and liver problems</li>
                                    <li> In the most severe cases, blood clots, kidney failure, or death (The severe cases affect only a very small percentage of women who undergo IVF—0.2 percent or less of all treatment cycles—and the very severe are an even smaller percentage)</li></ol></ol></li>
                                <li> Occurs at two stages:
                                    <ol>
                                        <li> Early - 1 to 5 days after your hGC-Orvidrel trigger</li> 
                                        <li> Late – 10 to 15 days after your hCG-Orvidreal trigger as a result of the hCG (if pregnancy occurs)</li>
                                    <ol>
                                    <li> The risk of severe complications is about 4 to 12 times higher if pregnancy occurs which is why sometimes hCG-Ovidrel trigger is withheld to reduce the possibility of this occurring.</li></ol></ol></li>
                                </ol>
                            </li>
                            <li> Cancer
                                <ol>
                                    <li> Many have worried that the use of fertility drugs could lead to an increased risk of cancer—in particular, breast, ovarian, and uterine (including endometrial) cancers. One must be careful in interpreting epidemiological studies of women taking fertility drugs, because all of these cancers are more common in women with infertility, so merely comparing women taking fertility drugs with women in the general population inevitably shows an increased incidence of cancer. When the analysis takes into account the increased cancer risk due to infertility per se, the evidence does not support a relationship between fertility drugs and an increased prevalence of breast or ovarian cancer.</li>
                                </ol>
                            </li> 
                            <li> Risks of Pregnancy
                                <ol>
                                <li> Pregnancies that occur with IVF are associated with increased risks of certain conditions (see Table below from the Executive Summary of a National Institute of Child Health and Human Development Workshop held in September 2005, as reported in the journal Obstetrics & Gynecology, vol. 109, no. 4, pages 967-77, 2007).
                                    <ol> 
                                        <li> Insert table (Potential risks in singleton IVF-conceived pregnancies)</li>
                                        <li> Key:
                                            <ol>
                                                <li> Absolute risk = % of IVF pregnancies in which the risk occurred</li>
                                                <li> Relative risk = the risk in IVF versus the risk in non-IVF pregnancies</li>
                                                <li> The numbers in parentheses (called the “Confidence Interval”) indicate the range in which the actual Relative Risk lies</li>
                                            </ol>
                                        </li>
                                        <li> Some of these risks stem from the higher average age of women pregnant by IVF and the fact that the underlying cause of infertility may be the cause of the increased risk of pregnancy complications</li>
                                    </ol>
                                <li> Multiple gestations
                                    <ol>
                                    <li> Currently more than 30% of IVF pregnancies are twins or higher-order multiple gestations (triplets or greater), and about half of all IVF babies are a result of multiple gestations</li>
                                    <li> Identical twinning occurs in 1.5% to 4.5% of IVF pregnancies</li>
                                    <li> IVF twins deliver on average three weeks earlier and weigh 1,000 gm less than IVF singletons.  Of note, IVF twins do as well as spontaneously conceived twins</li>
                                    <li> Triplet (and greater) pregnancies deliver before 32 weeks (7 months) in almost half of cases</li></ol></li>
                                <li> Abnormal Pregnancies
                                    <ol>
                                    <li> Although embryos are transferred directly into the uterus with IVF, ectopic (tubal, cervical and abdominal) pregnancies as well as abnormal intra-uterine pregnancies have occurred either alone or concurrently with a normal intra-uterine pregnancy</li>
                                    <li> Termination of ectopic/abnormal pregnancy:
                                        <ol>
                                        <li> Methotrexate (a weak chemotherapy drug)</li>
                                            <ol>
                                            <li> Side effects of methotrexate include nausea or vomiting, diarrhea, cramping, mouth ulcers, headache, skin rash, sensitivity to the sun and temporary abnormalities in liver function tests</li></ol>
                                        <li> Surgery</li>
                                            <ol>
                                            <li> Risks of surgery include the risks of anesthesia, scar tissue formation inside the uterus, infection, bleeding and injury to any internal organs</li></ol></ol></li>
                                    </ol>
                                    </ol>
                                </li>
                            </ol>
                            </div>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

     <!-- risks_to_offrping -->
    <div class="portfolio-modal modal fade" id="risks_to_offrping" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Risks To Offspring</h2>
                            <ol>
                            <li> Overall Risks
                                <ol>
                                <li> IVF babies may be at a slight increased risk for birth defects
                                    <ol>
                                    <li> Infertile couples, by definition, do not have normal reproductive function and might be expected to have babies with more abnormalities than a group of normally fertile couples.   This said, even if the studies suggesting an increased risk to babies born after IVF prove to be true, the absolute risk of any abnormal outcome appears to be small</li></ol></li>
                                <li> The risk for a multiple pregnancy [link to risks of multiple pregnancies] is higher for patients undergoing IVF, even when only one embryo is transferred.</li>
                                </li> 
                                <li> Multiple pregnancies are the greatest risk for babies following IVF</li>
                                <li> Some risk may also stem from the underlying infertile state, or from IVF techniques or both</li>
                                <li> Singletons conceived with IVF tend to be born slightly earlier than naturally conceived babies (39.1 weeks as compared to 39.5 weeks)</li>
                                <li> The risk of a singleton IVF conceived baby being born with a birth weight under 5 pounds nine ounces (2500 grams) is 12.5% vs. 7% in naturally conceived singletons</li>
                                </ol>
                            </li>
                            <li> Birth Defects
                                <ol>
                                <li> The rate of birth defects in IVF babies is 2.6-3.9% (versus 2-3% in the normal population). This difference is seen predominately in singleton males.</li>
                                <li> Imprinting Disorders</li>
                                <li> Childhood Cancers
                                <ol>
                                    <li> Most studies have not reported an increased risk </li></ol></li>
                                <li> Potential Risks in Singleton IVF Pregnancies
                                    <ol>
                                    <li> Insert table</li>
                                    <li> Key:
                                        <ol>
                                            <li> Absolute risk = % of IVF Pregnancies in which the risk occurred</li>
                                            <li> Relative Risk = the risk in IVF versus the risk in non-IVF pregnancies</li>
                                            <li> The numbers in parentheses (called the “Confidence Interval”) indicate the range in which the actual Relative Risk lies</li></ol></li></ol></li>
                                </ol>
                            </li>
                            <li> Risks of Multiple Pregnancy
                                <ol>
                                <li> Greatest risks:
                                    <ol>
                                    <li> Preterm labor and delivery</li>
                                    <li> Pre-eclampsia</li>
                                    <li> Gestational diabetes</li></ol></li>
                                <li> Additional risks:
                                    <ol>
                                    <li> Gall bladder problems</li>
                                    <li> Skin problems</li>
                                    <li> Excess weight gain</li>
                                    <li> Anemia</li>
                                    <li> Excessive nausea and vomiting</li>
                                    <li> Exacerbation of pregnancy-associated gastrointestinal symptoms including reflux and constipation</li>
                                    <li> Chronic back pain</li>
                                    <li> Intermittent heartburn</li>
                                    <li> Postpartum laxity of the abdominal wall</li>
                                    <li> Umbilical hernias</li>
                                    <li> Triplets and above increase risk to the mother of more significant complications including post-partum hemorrhage and transfusion</li></ol></li>
                                <li> Perinatal morbidity and mortality:
                                    <ol>
                                    <li> Prematurity
                                        <ol> 
                                        <li> Accounts for most of the excess perinatal morbidity and mortality associated with multiple gestations</li>
                                        <li> Moreover, IVF pregnancies are associated with an increased risk of prematurity, independent of maternal age and fetal numbers</li></ol></li>
                                    <li> Fetal growth problems and discordant growth among the fetuses</li> 
                                    <li> Multifetal  pregnancy reduction (where one or more fetuses are selectively terminated) reduces, but does not eliminate, the risk of these complications</li>
                                    <li> Fetal death rates for singleton, twin, and triplet pregnancies are 4.3 per 1,000, 15.5 per 1,000, and 21 per 1,000, respectively</li>
                                    <li> Vanishing twin
                                        <ol>
                                        <li> The death of one or more fetuses in a multiple gestation is more common in the first trimester and may be observed in up to 25% of pregnancies after IVF. Loss of a fetus in the first trimester is unlikely to adversely affect the surviving fetus or mother</li></ol></li>
                                    <li> Shared placenta
                                        <ol>
                                        <li> Demise of a single fetus in a twin pregnancy after the first trimester is more common when they share a placenta, ranging in incidence from 0.5% to 6.8%, and may cause harm to the remaining fetus</li>
                                        <li> Multiple fetuses (including twins) that share the same placenta have additional risks.
                                            <ol>  
                                            <li> Twin-to-twin Transfusion Syndrome
                                                a. A condition in which there is an imbalance of circulation between the fetuses 
                                                b. May occur in up to 20% of twins sharing a placenta  
                                                c. Excess or insufficient amniotic fluid may result from twin-to-twin transfusion syndrome.</li>  
                                            <li> Twins sharing the same placenta have a higher frequency of birth defects compared to pregnancies having two placentas</li>  
                                            <li> Twins sharing the same placenta appear to occur more frequently after blastocyst transfer</li>
                                            <li> Example from email of twinning??????????????????????????</li></ol></li></ol></li></ol></li>
                                <li> Complications:
                                    <ol>
                                    <li> Placenta previa and vasa previa are more common complications in multiple gestations</li>
                                    <li> Abruptio placenta also is more common and postpartum hemorrhage may complicate 12% of multifetal deliveries</li></ol></li>
                                <li> Consequences:
                                    <ol>
                                    <li> The major sequelae of prematurity
                                        <ol> 
                                        <li> Cerebral palsy</li>
                                        <li> Retinopathy of prematurity</li>
                                        <li> Chronic lung disease</li></ol></li>
                                    <li> The major sequelae of fetal growth restriction
                                        <ol> 
                                        <li> Polycythemia – increased concentration of red blood cells in the blood</li> 
                                        <li> Hypoglycemia – low blood sugar</li>
                                        <li> Necrotizing enterocolitis – death of gut tissue</li></ol></li></ol></li>
                                <li> Possible Additional Outcomes:
                                    <ol>
                                    <li> Rearing of twins and high-order multiples may generate physical, emotional, and financial stresses, and the incidence of maternal    depression and anxiety is increased in women raising multiples</li>
                                    <li> At mid-childhood, prematurely born offspring from multiple gestations have lower IQ scores, and multiple birth children have an increase in behavioral problems compared with singletons.  It is not clear to what extent these risks are affected by IVF</li></ol></li>
                                <li> Option of Selective Reduction
                                    <ol>
                                    <li> Patients with more than twins are faced with the options of continuing the pregnancy with all risks previously described, terminating the entire pregnancy, or reducing the number of fetuses in an effort to decrease the risk of maternal and perinatal morbidity and mortality</li>
                                    <li> Multifetal pregnancy reduction (MFPR) decreases risks associated with preterm delivery, but often creates profound ethical dilemmas<ol>
                                        <li> Pregnancy loss is the main risk (1% to 5%)</li></ol></li>
                                    <li> Insert table</li></ol></li></ol>
                            </li>
                            </ol>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

 <!-- alt_modal -->
    <div class="portfolio-modal modal fade" id="alt_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Alternatives to IVF</h2> 
                                <ol>
                                <li>The following are placed into the fallopian tube directly: 
                                <ol>
                                    <li> Gamete intrafallopian transfer (GIFT) – eggs and sperm </li>
                                    <li> Zygote intrafallopian transfer (ZIFT) – fertilized eggs</li>
                                    <li> Tubal embryo transfer (TET) – developing embryos</li></ol></li>
                            <li> Gametes (sperm and/or eggs) instead of embryos may be frozen for future attempts at pregnancy. This may also help to avoid future issues relating to disposition of any cryopreserved embryos.</li>
                            </li>
                            </ol>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

 <!-- social_modal -->
    <div class="portfolio-modal modal fade" id="social_modal" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>Social/Legal</h2>
                            <ol>
                            <li> Ethical and Religious Considerations in Infertility Treatm</li>
                                <li> IVF can involve the production of excess embryos and/or “high-order” multiple pregnancies (triplets +)</li>
                                <li> We encourage patients and partners who desire to consult with their religious or ethical community for guidance on their treatment</li></ol></li>
                            <li> Psychosocial Effects of Infertility Treatment
                                <ol>
                                    <li> A diagnosis of infertility can be a devastating and life-altering event.</li>
                                    <li> Infertility and its treatment can affect a patient and her partner medically, financially, socially, emotionally and psychologically.</li>
                                    <li> Feelings of anxiousness, depression, isolation, and helplessness are not uncommon among patients undergoing treatment.</li>
                                    <li> Strained and stressful relations with partners and other loved ones are not uncommon as treatment progresses.</li>
                                    <li> Our healthcare team is available to address emotional and physical symptoms that can accompany infertility.</li>
                                    <li> In addition to working with our health care team to minimize emotional impacts, patients may consider working with mental health professionals specializing in infertility care.</li>
                                    <li> While it is normal to experience emotional ups and downs, it is important to recognize severe feelings. </li>
                                    <li> If you experience any of the following for a prolonged period of time, you may benefit from working with a mental health professional [LINK TO Our health care team can assist you in locating a qualified mental health professional who is familiar with the emotional experience of infertility, or you can contact a national support group such as RESOLVE, (www.resolve.org, Tel. 1-888-623-0744) or The American Fertility Association (AFA), (www.theafa.org, Tel: 1-888-917-3777).
                                            <ol>
                                                <li> loss of interest in usual activities </li>
                                                <li> depression that doesn't lift </li>
                                                <li> strained interpersonal relationships (with partner, family, friends and/or colleagues) </li>
                                                <li> difficulty thinking of anything other than your infertility </li>
                                                <li> high levels of anxiety</li>
                                                <li> diminished ability to accomplish tasks</li> 
                                                <li> difficulty with concentration </li>
                                                <li> change in your sleep patterns (difficulty falling asleep or staying asleep, early morning awakening, sleeping more than usual for you) </li>
                                                <li> change in your appetite or weight (increase or decrease) </li>
                                                <li> increased use of drugs or alcohol </li>
                                                <li> thoughts about death or suicide </li>
                                                <li> social isolation </li>
                                                <li> persistent feelings of pessimism, guilt, or worthlessness </li>
                                                <li> persistent feelings of bitterness or anger</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </li>

                            <li> Legal Considerations to Offspring
                                <ol>
                                    <li> The law regarding embryo cryopreservation, thaw, parent-child status of any resulting child or children may be unsettled in the state in which the ART program is located</li>
                                    <li> ART Program does not give any legal advise</li>
                                    <li> You may consult a lawyer who is experienced in the area of reproductive law and embryo cryopreservation and disposition.</li>
                                </ol>
                            </li>
                            <li> Reporting Outcomes

                                <p>The 1992 Fertility Clinic Success Rate and Certification Act requires the Centers for Disease Control and Prevention (CDC) to collect cycle-specific data as well as pregnancy outcome on all assisted reproductive technology cycles performed in the United States each year and requires them to report success rates using these data.  Consequently, data from my/our IVF procedure will be provided to the CDC, and to the Society of Assisted Reproductive Technologies (SART) of the American Society of Reproductive Medicine (ASRM) (if my/our clinic is a member of this organization). The CDC may request additional information from the treatment center or contact me/us directly for additional follow-up. Additionally, my/our information may be used and disclosed in accordance with HIPAA guidelines in order to perform research or quality control. All information used for research will be de-identified prior to publication. De-identification is a process intended to prevent the data associated with my/our treatment being used to identify me/us as individuals.</p> 

                                <p>In addition, ARI physicians and scientists may include information about IVF procedures in medical publications and professional presentations.  In these publications and presentations the identities of the patients involved in the IVF procedure remain confidential.  ARI keeps patient medical records and information confidential through standard procedures for the protection of patient identities.</p> </li>


                            <li> Financial

                                <p>I/We have had a financial consult and have been given a copy of our benefits from the insurance cards we provided to ARI.  I/We have been encouraged to check our own benefits.  I/We are personally financially responsible for the expense of this treatment and any additional expenses for the medical problems or those for a child.  Expenses for IVF treatment consist of the cost of the medications, laboratory, facility and professional fees.  All questions have been answered to my/our satisfaction prior to starting treatment.</p></li>
                            </ol>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>


<!-- template -->
    <div class="portfolio-modal modal fade" id="template" tabindex="-1" role="dialog" aria-hidden="true">
        <div class="modal-content">
            <div class="close-modal" data-dismiss="modal" onclick="success()">
                <div class="lr">
                    <div class="rl">
                    </div>
                </div>
            </div>
            <div class="container">
                <div class="row">
                    <div class="col-lg-8 col-lg-offset-2">
                        <div class="modal-body">
                            <!-- Project Details Go Here -->
                            <h2>template</h2>
                            <button type="button" onclick="success()" class="btn btn-primary" data-dismiss="modal"><i class="fa fa-times"></i> Close </button>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- jQuery -->
    <script src="js/jquery.js"></script>

    <!-- jQuery Cookie -->
    <script src="js/jquery-cookie.js"></script>

    <script src="js/underscore.js"></script>

    <!-- Bootstrap Core JavaScript -->
    <script src="js/bootstrap.min.js"></script>

    <!-- Plugin JavaScript -->
    <script src="http://cdnjs.cloudflare.com/ajax/libs/jquery-easing/1.3/jquery.easing.min.js"></script>
    <script src="js/classie.js"></script>
    <script src="js/cbpAnimatedHeader.js"></script>

    <!-- Contact Form JavaScript -->
    <script src="js/jqBootstrapValidation.js"></script>
    <script src="js/contact_me.js"></script>

    <!-- Custom Theme JavaScript -->
    <script src="js/agency.js"></script>

    <script src="js/sweet-alert.min.js"></script>

    <script src="js/myCookie.js"></script>
    <!-- Carousel -->
    <script src="js/jquery.jcarousel.js"></script>

    

    

</body>

</html>
